Switching from Mounjaro to Foundayo: Your Guide to a Safe Transition

Switching from Mounjaro to Foundayo means moving from once-weekly tirzepatide injections to a once-daily orforglipron tablet. Although both medicines are used for weight management, they contain different active ingredients and work differently, so there is no manufacturer-approved dose-for-dose conversion between them.

For this reason, switching from Mounjaro to Foundayo should be planned with a qualified prescriber rather than managed independently. An individual assessment can help establish whether the change is appropriate for your treatment needs, while ongoing monitoring can track your response as you adjust to Foundayo.

Key Insights for Switching to Foundayo

• Switching from Mounjaro to Foundayo means moving from weekly tirzepatide injections to a daily orforglipron tablet.
• There is no manufacturer-approved dose-for-dose conversion between the two treatments.
• A prescriber should determine the appropriate timing and Foundayo starting dose based on individual circumstances.
• Clinical trials reported greater average weight loss with Mounjaro, although the medicines have not been directly compared head-to-head.
• Appetite control, weight-loss progress and digestive side effects may change during the transition.
• Ongoing clinical monitoring, balanced nutrition and regular physical activity can support longer-term weight management.

Why Do People Consider Switching from Mounjaro to Foundayo?

Switching may be considered when Mounjaro works but weekly injections no longer suit your lifestyle or treatment preferences. As a daily tablet, Foundayo provides a needle-free alternative that some people may find easier to manage, particularly when travelling or following a regular routine.

You may discuss switching with your prescriber if you:

• prefer a tablet to weekly injections
• find injection pens inconvenient to store or carry
• want a treatment that fits more easily into daily life
• have experienced tolerability issues with Mounjaro
• have changing weight-management goals or treatment needs

However, convenience is only one factor. Your response to Mounjaro, side effects, medical history and future weight-loss goals should also be considered before deciding whether Foundayo is suitable for you.

Is Switching From Mounjaro to Foundayo Safe?

Yes, switching from Mounjaro to Foundayo may be appropriate for some patients, but it is not a direct or automatic swap. Both are prescription medicines, so a prescriber should assess your current Mounjaro dose, treatment response, side effects and overall health before deciding whether Foundayo is suitable for you.

Careful timing is also important because tirzepatide remains active in the body after your final Mounjaro injection. The treatments should not be overlapped unless specifically directed by a prescriber. Instead, they can determine when to stop Mounjaro, when to start Foundayo and which starting dose is appropriate.

How Does Foundayo Differ From Mounjaro?

Mounjaro and Foundayo support weight management through different formulations and mechanisms. Mounjaro contains tirzepatide, which acts on both GLP-1 and GIP receptors and is administered as a once-weekly injection. Foundayo contains orforglipron, an oral GLP-1 receptor agonist taken once daily. Foundayo can also be taken with or without food and does not require injections, offering greater flexibility for people who prefer an oral treatment.

Foundayo vs Mounjaro: Key Differences

Mounjaro vs Foundayo: How Do Weight-Loss Results Compare?

Clinical trial data indicate greater average weight loss with Mounjaro. In the 72-week SURMOUNT-1 trial, participants achieved reductions of 16.0% with 5 mg, 21.4% with 10 mg and 22.5% with 15 mg tirzepatide, based on the efficacy estimand.

The ATTAIN-1 trial evaluated orforglipron over the same period, with 36 mg resulting in a 12.4% average reduction. Among participants receiving 36 mg, 59.6% lost at least 10% of their body weight, 39.6% lost at least 15% and 20.1% lost at least 20%. This trial dose should not be confused with current Foundayo dosing strengths.

Important Note: These findings come from separate trials, not a direct head-to-head comparison. Results can vary according to treatment response, tolerability, adherence, dose and lifestyle changes.

When Should You Start Foundayo After Your Last Mounjaro Dose?

A typical approach is to start Foundayo around one week (7 days) after your final weekly Mounjaro injection, approximately when your next Mounjaro dose would have been due. Tirzepatide remains active in the body after the last injection, so this interval allows the previous dose to begin clearing while avoiding an unnecessarily long break between treatments.

The exact timing should still be confirmed by your prescriber, as your Mounjaro dose, treatment response, tolerability, side effects and overall health can influence the transition. If more than 14 days have passed since your last Mounjaro injection, the usual switching approach may no longer be appropriate, and your prescriber should reassess your treatment history before deciding when and at what dose Foundayo should be started.

What Dose of Foundayo May You Start After Mounjaro?

Your current Mounjaro dose may be considered when a clinician plans your switch to Foundayo. However, tirzepatide and orforglipron are different medicines, so the doses below should not be interpreted as direct equivalents or used to switch treatment without a clinical assessment.

Once your prescriber has selected an appropriate starting dose, further increases should be guided by your response and tolerability rather than attempting to match your previous Mounjaro dose.

Important Note: This is an indicative switching guide, not an approved dose-for-dose conversion. The licensed Foundayo schedule normally starts at 0.8 mg daily and increases gradually, so do not select or change your dose without your prescriber’s guidance.

What Should You Expect After Switching From Mounjaro to Foundayo?

Your response may change after switching because Mounjaro and Foundayo work differently. As your body adjusts from a weekly injection to a daily tablet, you may notice changes in:

• appetite and hunger levels
• food cravings and feelings of fullness
• rate of weight loss
• digestive side effects
• weight stability during maintenance

A temporary slowdown in weight loss does not necessarily mean Foundayo is ineffective. However, reduced appetite control may increase food intake and contribute to weight regain. Following a balanced calorie-controlled diet, staying physically active and taking your treatment consistently can help support your progress.

Regular clinical reviews are particularly useful during the transition. Book a free consultation if you experience persistent or severe side effects, repeated vomiting, severe abdominal pain or signs of dehydration.

Conclusion: Making the Switch to Foundayo

Switching from Mounjaro to Foundayo can provide a needle-free approach to weight management. Whether it is the right next step depends on your individual needs, treatment experience and longer-term goals. A clinically supervised transition can help ensure your treatment remains appropriate as your weight-management needs evolve.

If you are considering Foundayo, Mayfair Weight Loss Clinic can assess your suitability and provide personalised clinical guidance. Our qualified prescribers can support you throughout treatment with ongoing reviews, helping you stay informed and confident about your weight-management plan.

FAQs About Switching From Mounjaro to Foundayo

Can I switch to Foundayo if I have not reached my target weight on Mounjaro?

Potentially. Not reaching your target weight does not automatically rule out Foundayo, but a prescriber should review your progress and reasons for changing treatment before deciding whether it is suitable.

Do I need a new prescription to change from Mounjaro to Foundayo?

Yes. Foundayo is a prescription-only medicine in the UK, so you will need an appropriate clinical assessment and prescription rather than using an existing Mounjaro prescription.

Can I switch to Foundayo because I am afraid of needles?

A preference to avoid injections may be a reason to discuss Foundayo with your prescriber. It is taken orally, making it a potential option for people who find regular self-injection difficult.

Can I switch back to Mounjaro if Foundayo does not suit me?

A further treatment change may be possible, but you should not restart Mounjaro yourself. Your prescriber will need to reassess your circumstances and determine an appropriate treatment plan.

Can I drink alcohol while taking Foundayo after Mounjaro?

There is no general requirement to completely avoid alcohol, but it may worsen digestive symptoms in some people. Follow your prescriber’s advice and consider limiting alcohol if it affects your tolerability.

Does Foundayo need to be refrigerated like Mounjaro?

Foundayo tablets do not require the same refrigerated storage routine as Mounjaro injection pens. Always follow the storage instructions supplied with your medicine to maintain its quality.

Can I take other medicines while using Foundayo?

Possibly, but your prescriber should know about all prescription medicines, over-the-counter products and supplements you take. This allows potential interactions or changes in medicine absorption to be considered.

Can I switch from Mounjaro to Foundayo for weight maintenance?

Foundayo may be considered as part of longer-term weight management for suitable patients. Whether it is appropriate for maintenance depends on your treatment history, current weight-management needs and clinical assessment.